Evidence map›Paper›PMID 19657394›Full record

ArticlePloS one2009

A versatile viral system for expression and depletion of proteins in mammalian cells.

Eric Campeau, Victoria E Ruhl, Francis Rodier, Corey L Smith, Brittany L Rahmberg, Jill O Fuss, Judith Campisi, Paul Yaswen, Priscilla K Cooper, Paul D Kaufman

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 676 papers.

0numbers the graph read from it
0cells of the map it votes in
676citing papers in PubMed
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

676 citing papers in PubMed, 1,029 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. RAN Translation-Coupled Decay of theInternational journal of molecular sciences · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

616 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Eric CampeauProgram in Gene Function and Expression, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America. Eric.Campeau@umassmed.edu
Victoria E Ruhl
Francis Rodier
Corey L Smith
Brittany L Rahmberg
Jill O Fuss
Judith Campisi
Paul Yaswen
Priscilla K Cooper
Paul D Kaufman
Lawrence Berkeley National Laboratory · USUniversity of Massachusetts Chan Medical School · US

Funding

Transcription-Coupled & Replication-Associated Excision RepairP01CA092584 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI John A. Tainer · 2001 to 2026
$89.6M
THE IMPACT OF CELLULAR DEFENSE ON THE ROLE OF Ku80 IN GENOME MAINTENANCE AND LONGP01AG017242 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI VIJG, JAN · 1999 to 2023
$46.1M
Systems-Based Predictions of Responses to Cancer TherapyU54CA112970 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI GRAY, JOE W. · 2004 to 2014
$27.1M
Regulation of repetitive chromatin structures during the human cell cycleR01GM055712 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KAUFMAN, PAUL D. · 1997 to 2014
$5.1M
Mechanisms for Transcription-Coupled Repair in Human CellsR01CA063503 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI COOPER, PRISCILLA K. · 1994 to 2010
$3.9M
Structural Biology of MDC1, a Novel Checkpoint MediatorF32CA108393 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI FUSS, JILL O · 2004 to 2006
$154k
Mechanisms and stoichiometry of histone depositionF32GM076863 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SMITH, COREY LEWIS · 2006 to 2008
$145k
NCI NIH HHS 1F32CA108393NCI NIH HHS F32 CA108393NCI NIH HHS P01 CA092584NCI NIH HHS R01 CA063503NCI NIH HHS U54 CA112970NIA NIH HHS AG017242NIA NIH HHS P01 AG017242NIGMS NIH HHS 5 F32 GM076863-03NIGMS NIH HHS F32 GM076863NIGMS NIH HHS R01 GM055712NIGMS NIH HHS R01 GM557
6 · The paper itself

Abstract

The ability to express or deplete proteins in living cells is crucial for the study of biological processes. Viral vectors are often useful to deliver DNA constructs to cells that are difficult to transfect by other methods. Lentiviruses have the additional advantage of being able to integrate into the genomes of non-dividing mammalian cells. However, existing viral expression systems generally require different vector backbones for expression of cDNA, small hairpin RNA (shRNA) or microRNA (miRNA) and provide limited drug selection markers. Furthermore, viral backbones are often recombinogenic in bacteria, complicating the generation and maintenance of desired clones. Here, we describe a collection of 59 vectors that comprise an integrated system for constitutive or inducible expression of cDNAs, shRNAs or miRNAs, and use a wide variety of drug selection markers. These vectors are based on the Gateway technology (Invitrogen) whereby the cDNA, shRNA or miRNA of interest is cloned into an Entry vector and then recombined into a Destination vector that carries the chosen viral backbone and drug selection marker. This recombination reaction generates the desired product with >95% efficiency and greatly reduces the frequency of unwanted recombination in bacteria. We generated Destination vectors for the production of both retroviruses and lentiviruses. Further, we characterized each vector for its viral titer production as well as its efficiency in expressing or depleting proteins of interest. We also generated multiple types of vectors for the production of fusion proteins and confirmed expression of each. We demonstrated the utility of these vectors in a variety of functional studies. First, we show that the FKBP12 Destabilization Domain system can be used to either express or deplete the protein of interest in mitotically-arrested cells. Also, we generate primary fibroblasts that can be induced to senesce in the presence or absence of DNA damage. Finally, we determined that both isoforms of the AT-Rich Interacting Domain 4B (ARID4B) protein could induce G1 arrest when overexpressed. As new technologies emerge, the vectors in this collection can be easily modified and adapted without the need for extensive recloning.

Indexed as

Genetic VectorsAnimalsBase SequenceCell LineDNA, ComplementaryDNA PrimersElectrophoresis, Polyacrylamide GelFlow CytometryFluorescent Antibody TechniqueHumansProteinsRecombination, GeneticRetroviridaeRNARNA InterferenceDNA, ComplementaryDNA PrimersProteinsRNA

Identifiers

PMID19657394
PMCPMC2717805
OpenAlexW2170725518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.